April 16, 2007 – Finesse Solutions, LLC, Applikon Biotechnology B.V. and Applikon BiotechnologyInc, announced the launch of a solution for migrating 1010/1030 controllers onto the DeltaV enabledTruLogic™ Controller and TruBio™ OS software. This solution, known as TruConnect™, is designed toenable users of either the Applikon 1010 and/or 1030 controllers to take full advantage of the additionalfunctionality available when these units are placed on a DeltaV controller enabled by the TruBio™ OS.

The role of TruConnect™ is to act as a serial interface between the Applikon 1010/1030 controller andDeltaV. To accomplish this role TruConnect™ converts the ASCII command set of the Applikon controllerand maps it to the Modbus protocol used by the TruBio™ OS. The design of TruConnect™ allowsfor a single DeltaV enabled TruLogic™ Controller to manage up to eight (8) of the Applikon 1010/1030units at a competitive price.

Applikon’s President, John Chory, stated, “The collaboration with Finesse has enabled us to ensureour customers that their substantial investment in our control products over the years can be easilymigrated to an Applikon supported DeltaV solution whenever they require.

”We developed our TruConnect™ technology to assist industry leaders such as Applikon in realizinga new, fast, reliable and cost competitive way of interfacing their devices to DeltaV,” said Larry West,Executive V.P. Sales and Marketing at Finesse.

About Finesse
California based Finesse is a global leader in process measurement and control technologies. Ourfamily of products – TruBio™, TruLogic™, TruViu™, TruCell™, TrupH™, and TruDO™, provide comprehensive solutions for measurement and control processes in the biotech and pharmaceutical industries.For more information, please visit us at www.finesse.com

About Applikon Biotechnology B.V.Applikon Biotechnology is a privately owned Dutch company that develops, manufactures and suppliesbioreactor systems for research and production. Founded in 1973, Applikon has grown into a globalenterprise capable of supplying a broad and diverse line of bioreactor systems and a leading supplierof bioreactor solutions for R&D, Pilot and cGMP. Applikon’s autoclavable bioreactor systems are the worldwide industry standard. Applikon controllers comply with the highest standards applied in thepharmaceutical industry for bio-processes under GMP conditions.Applikon is headquartered in Schiedam, the Netherlands, with major operations in Foster City (USA),Eckington (UK), and distributors in more than 16 countries. For more information, please visit us at www.applikon-bio.com.

Media: Kimberly Lozada, 408-327-6613

AUSTIN, TEXAS (March 24, 2008) – Emerson Process Management has entered an agreement with Finesse Solutions, LLC, Irvine, CA, a manufacturer of measurement and control solutions for life sciences process applications. Emerson will provide Finesse’s customers with integration and process automation services between Emerson’s DeltaV digital automation system and Finesse’s TruBio Bioreactor Control System on projects developed by Finesse’s direct sales force for bioprocess drug development and production.

The TruBio system, which is powered by the DeltaV controller, is an "open" configurable software solution developed specifically for the life sciences industry. The embedded configurable control logic for pH, dissolved oxygen, temperature, agitation, and a host of other parameters provides flexible control for both cell culture and fermentation applications.

TruBio is designed to enable OEM's, system integrators, engineering firms and end users alike to quickly customize the control system to meet their individual application requirements. TruBio's open configurable design has the power to compress project schedules and reduce engineering costs while still facilitating customization. Emerson’s role will be to integrate and scale up the embedded DeltaV controller in Finesse’s products into a larger DeltaV system, or expand it to a plant-wide system.

“The agreement between Finesse and Emerson will allow Finesse’s direct sales force to expand the application of the TruBio system from research and development into manufacturing,” said Barb Paldus, CEO of Finesse Solutions. “Life sciences customers will be able to achieve end-to-end process data sharing and faster scale-up through this combined solution.”

“I see this as a positive step forward between our two companies to offer our mutual customers integrated solutions based on Emerson’s PlantWeb technologies,” said Terry Moore, vice president, Life Sciences Industry Center of Emerson Process Management.

PlantWeb is an innovative digital architecture that has been proven in thousands of installations globally, including Life Science applications where benefits include fast startup and operational excellence. PlantWeb is powered by the DeltaV system that digitally networks with Rosemount pressure, flow, level and temperature instruments; Fisher control valves with FIELDVUE digital valve controllers; Micro Motion Coriolis meters and Rosemount analyzers.

About Finesse Solutions
California-based Finesse Solutions, LLC, leads the way in developing new measurement and control technologies, in order to enable the transition to single-use systems, bring new capabilities to existing bioreactor platforms, and harmonize global bio-process information transfer. Our current product family provides comprehensive measurement and control solutions for upstream processes in the biotech and pharmaceutical industries.

About Emerson Process Management
Emerson Process Management, an Emerson business, is a leader in helping businesses automate their production, processing and distribution in the power, water and wastewater treatment, chemical, oil and gas, refining, pulp and paper, food and beverage, life sciences, and other industries. Emerson brands include PlantWeb, Ovation, SmartProcess, Fisher, Micro Motion, Rosemount, Mobrey, Daniel, Bristol, DeltaV, and AMS Suite.

About Emerson
Emerson (NYSE:EMR), based in St. Louis, is a global leader in bringing technology and engineering together to provide innovative solutions to customers through its network power, process management, industrial automation, climate technologies, and appliance and tools businesses. Sales in fiscal 2007 were $22.6 billion.

Emerson Process Management Contact Information:
Phone Inquiry: 512-835-2190
Emerson Process Management web site

SANTA CLARA, Calif., March 20 /PRNewswire/ -- Finesse Solutions, LLC, a manufacturer of measurement and control solutions for life sciences process applications, is pleased to announce the opening of their new E-Commerce Store effective March 25th. Finesse will be introducing this new E-Store at Interphex in Philadelphia. The new E-Store has been added to the Finesse web site (http://www.finesse.com) so that customers can harness the power of the web and purchase sensors and other accessories on-line.

"We are delighted to open this new E-Store for our customers around the world. Our goal is to enhance the total customer experience and make it as easy as possible for our customers to get what they want, when they want it from Finesse. This E-Store is one of the first steps we will be taking to enhance the overall customer experience at Finesse," said John O'Connell, VP of Sales and Business Development at Finesse Solutions. "Industry acceptance and customer demand has been growing very quickly for our solutions. We need to make sure that our customers can get access to us any time from any place in the world." Customers who visit Finesse at Interphex will be given the opportunity to register for the site and see demonstrations on how to access the site and purchase on line.

About Finesse Solutions, LLC
California-based Finesse Solutions, LLC, leads the way in developing new measurement and control technologies, in order to enable the transition to single-use systems, bring new capabilities to existing bioreactor platforms, and harmonize global bio-process information transfer. Our current product family provides comprehensive measurement and control solutions for upstream processes in the biotech and pharmaceutical industries.

May 2nd , 2008 – Finesse Solutions, LLC, Santa Clara, CA, a manufacturer of measurement and control solutions for life sciences process applications, announced the release of TruViu™ PLSS, a vessel utility tower system for pilot and small scale production applications. The PLSS package expands on the RDPD system to include substantially more I/O capability and NEMA 4X enclosures. TruViu™ PLSS consists of an I/O tower, a transmitter tower, an optional pump tower, and/or an optional TruFlow™ gas manifold. TruViu™ PLSS brings the benefits of DeltaV reliability and scalability in an affordable package. It interfaces easily with the TruLogic™ Controller and TruBio™ software to deliver optimal bioprocess control.

TruViu™ PLSS is designed to provide a flexible and plug-and-play configuration, in order to maximize ease-of-use, simplify installation, and provide scheduled maintenance. The modular design allows TruViu™ PLSS components to be mounted on an industrial cart and be used for bioprocess runs on different single-use pilot and small-scale production vessels.

TruViu™ PLSS minimizes floor space while expanding hardware capability to 6 pumps, 6 MFCs, 6 weigh scale inputs, and redundant transmitters for critical process parameters as pH, dissolved oxygen and temperature. TruViu™ PLSS utilizes state-of-the art transmitters that enable sensor calibration algorithms and full sensor diagnostics, and is upgradable to TruFluor disposable sensor technology for single-use applications. TruViu™ PLSS therefore delivers the competitive advantages of increased performance, efficiency and reliability, reduced operating costs and improved ease-of-use in a future-proof package.

According to Finesse Solutions VP Hardware, Dr. Alfy Riddle, "Our end users first asked for low cost and minimal footprint systems, so we developed the TruViu™ RDPD. Then they asked us to expand the hardware capability to take full advantage of our TruBio™ software as well as operate in a wash-down environment. We responded with our TruViu™ PLSS."

About Finesse Solutions, LLC
California-based Finesse Solutions, LLC, leads the way in developing new measurement and control technologies, in order to enable the transition to single-use systems, bring new capabilities to existing bioreactor platforms, and harmonize global bio-process information transfer. Our current product family provides comprehensive measurement and control solutions for upstream processes in the biotech and pharmaceutical industries.

Media: Kimberly Lozada, 408-327-6613

May 05, 2008 – Finesse Solutions, LLC, Santa Clara, CA, a manufacturer of measurement and control solutions for life sciences process applications, announced the appointment of Basil Zimmo as its Vice-President of Software. Basil brings over 19 years of international program and senior management experience, with a focus on implementing high efficiency engineering, resource optimization, and global performance metrics. Basil was most recently a Senior Program Manager for handheld products at Research in Motion (RIM). Prior to joining RIM, Basil held senior management roles at Picarro Canada, Inc. and telecommunications companies such as Nortel Networks and JDS Uniphase, and has held positions at semiconductor chip companies such as AMD, Mitel Semiconductor, Phillips Semiconductor, GEC Plessey and Hughes Aircraft Company.

At Finesse Solutions, Mr. Zimmo will lead the new, Santa Clara-based software team in developing the TruBio bioreactor control platform. Mr. Zimmo said, “I am delighted to join Finesse, and work closely with both sensor and hardware teams to develop the next generation TruBio software. Finesse has a unique opportunity to innovate and address the evolving needs of bio-processing applications.”

According to Finesse Solutions CEO Dr. Barbara Paldus, “We are delighted to embark on developing future versions of TruBio software based on state-of-the art programming platforms, that will future-proof our offering and add new capabilities for end users. We look forward to offering end users significantly improved code and novel, advanced features in the near future.”

About Finesse Solutions, LLC
California-based Finesse Solutions, LLC, leads the way in developing new measurement and control technologies, in order to enable the transition to single-use systems, bring new capabilities to existing bioreactor platforms, and harmonize global bio-process information transfer. Our current product family provides comprehensive measurement and control solutions for upstream processes in the biotech and pharmaceutical industries.

Media: Kimberly Lozada, 408-327-6613

April 2, 2008 ─ GE Healthcare has announced a strategic partnership with Finesse Solutions LLC to develop a WAVE BioreactorTM control package based on the Finesse TruLogicTM controller with TruBioTM SCADA.

The TruBio Bioprocess Control Operating System is an open, fully configurable, software solution, developed with GAMP4 methods and validated for cGMP applications. TruBio software is supplied with algorithms for controlling WAVE Bioreactor parameters such as pH, dissolved oxygen, temperature, rocking speed, pressure, aeration, and weight, as well as supporting redundant sensor loops for pH or dissolved oxygen. TruBio software has been optimized for DeltaV-enabled TruLogic Controllers.

Finesse highlighted this collaboration at Interphex by displaying a WAVE BioreactorTM communicating with their TruBio software.

For more information on the various control platforms Finesse offers, visit their website: www.finesse.com

For more information on the WAVE BioreactorTM system and supporting single-use bioprocessing tools, visit the GE Healthcare WAVE Products website:
www.gelifesciences.com/wave

September 24, 2008 - Finesse Solutions, LLC, a manufacturer of measurement and control solutions for life sciences process applications, is pleased to announce improvements to their E-Commerce Store that makes shopping for sensors and transmitters even easier. The E-Store can be found at the Finesse web site (www.finesse.com/shopfinesse). Customers can now easily purchase bioprocess sensors and accessories on-line anywhere in the world anytime of the day or night.

Customers can Point. Click. And Save. 20% off their first purchase of bioprocess pH, DO and cell density sensors and transmitters when they enter the Coupon code TRUSAVINGS at www.finesse.com/shopfinesse.

About Finesse Solutions, LLC
California-based Finesse Solutions, LLC, leads the way in developing new measurement and control technologies, in order to enable the transition to single-use systems, bring new capabilities to existing bioreactor platforms, and harmonize global bio-process information transfer. Our current product family provides comprehensive measurement and control solutions for upstream processes in the biotech and pharmaceutical industries.

September 30, 2008 – Finesse Solutions, LLC, Santa Clara, CA, a manufacturer of measurement and control solutions for life science process applications, announced the release of version 3.4 of its TruBio bioreactor control software. TruBio 3.4 software can automate bioreactors across a wide variety of bioreactors, ranging from 1L bench top R&D glass to 1000L cGMP production single-use vessels. TruBio 3.4 software is optimized for DeltaV version 9.3 from Emerson Process Management in order to bring ease of use and reliability to the user.   

TruBio 3.4 control strategies can be configured by end users with no prior DeltaV programming knowledge, using pull-down menus or graphical faceplates. In addition to improvements in existing features such as the user interface, vessel configuration management, and on-line parameter updates, TruBio 3.4 software provides new features including data management and reporting for multi-sensor calibration, conditional alarming, asymmetrical deadband limits, and full integration of the TruConnect SCADA software for seamless connection of external third party peripherals or bioreactor controllers into the DeltaV network.

According to Finesse Solutions, CTO, Dr. Mark Selker, “Our new software team almost completely re-coded the TruBio 3.4 software platform in an effort to future-proof our offering and add new capabilities for end users. Our platform is now ready for conversion to state-of-the-art programming in C#.NET for its 2009 release.” Basil Zimmo, VP of Software, added, “Finesse is committed to using the leading software platforms from Emerson Process Management and Microsoft. We look forward to continuing to bring novel, advanced features in future TruBio releases, and bringing the latest software capabilities to our end users.”

About Finesse Solutions, LLC
California-based Finesse Solutions, LLC, leads the way in developing new measurement and control technologies, in order to enable the transition to single-use systems, bring new capabilities to existing bioreactor platforms, and harmonize global bio-process information transfer. Our current product family provides comprehensive measurement and control solutions for upstream processes in the biotech and pharmaceutical industries. For more information, please visit us at www.finesse.com.

Media: Barbara Paldus, (408) 327-6623

December 17, 2008 - Finesse Solutions, LLC, Santa Clara, CA, a manufacturer of measurement and control solutions for life science process applications, announced the introduction of an autoclavable optical dissolved oxygen sensor that gives better performance and requires less maintenance than traditional DO sensors currently used in the industry.

 “Our new TruDO Optical sensor ushers in next-generation sensor technologies for bioprocess applications,” said Finesse CTO Dr. Mark Selker. Currently available for evaluation, TruDO sensors and accessories will be generally commercially available in January 2009.

A direct replacement for traditional polargraphic DO sensors, TruDO Optical sensors use phase fluorimetry to measure dissolved oxygen. Their optical approach provides three key benefits: faster measurement response time, minimal long-term drift and lower cost.  TruDO Optical sensors reduce operating costs because they do not require polarization or electrolyte solution. They also lower capital costs as they do not require a transmitter: they can output a 4 to 20 mA analog or ModBus digital signal directly to the bioreactor controller.  Additionally, they can be used as a drop-in replacement for an electrochemical probe, by emulating an output current in nA.to an existing transmitter.

TruDO Optical sensors have a VarioPin connection on a Pg13.5 threaded cap, a 12 mm diameter, and are available in 120 mm, 160 mm, 225 mm, 325 mm and 425 mm lengths. The TruDO Optical family of products will also include cables, housings, replacement optical caps and power converters.

"TruDO Optical enhances our reusable sensor product family and brings new capabilities along with greater ease of use,” Dr. Selker added. “With the recent introduction of TruFluor, an innovative next-generation single-use optical DO sensor, Finesse offers both single-use and reusable DO sensor solutions to the market.”

   
About Finesse Solutions, LLC
California-based Finesse Solutions, LLC, leads the way in developing new measurement and control technologies, in order to enable the transition to single-use systems, bring new capabilities to existing bioreactor platforms, and harmonize global bio-process information transfer. Our current product family provides comprehensive measurement and control solutions for upstream processes in the biotech and pharmaceutical industries. For more information, please visit us at www.finesse.com.

Media: Barbara Paldus, (408) 327-6623

March 5th, 2009 – Finesse Solutions, LLC, Santa Clara, CA, a manufacturer of measurement and control solutions for bioprocess applications, and Nova Biomedical, Waltham, MA, a world leader in biotechnology process monitoring announced the release of a TruBio™ plug-in for OPC connectivity between TruBio control software and Nova FLEX® analyzers. OPC is the de facto standard for data exchange between process control systems and different hardware platforms. 

OPC-based communication between a Nova FLEX® and TruBio™ reduces errors or time delays of manual sampling, and provides automated reporting of results. More sophisticated process control strategies can be implemented, process parameters can be adjusted without human intervention, and, when process alarm conditions occur, off-site personnel can be alerted and/or automatic corrective action be taken. Additionally, all off-line FLEX data can be directly consolidated into the TruBio/DeltaV historian, or used in automated batch report generation for electronic records. 

Basil Zimmo, Vice President of Software at Finesse, stated, “The Nova FLEX®-TruBio plug-in will reduce operating costs: printouts of standalone analyzer results will no longer have to be manually attached or tracked.   Furthermore, this product will improve bioprocess quality and yield: programming a Nova FLEX to automatically standardize an in-situ probe or using FLEX cell viability data in real-time algorithms will increase the accuracy and repeatability of control.”

“By redefining the standard associated with offline data to include complete integration and the value of those data as they are applied to the bioprocess automatically, Nova and Finesse continue to provide the cutting edge technology required to bring the biotechnology industry into a new era of effectiveness and profitability, thereby allowing our customers real-time benefits that, until now, were impossible.” said Lyle Peshek, National Sales Manager for Nova Biomedical.

About Finesse Solutions, LLC
California-based Finesse Solutions, LLC, leads the way in developing new measurement and control technologies, in order to enable the transition to single-use systems, bring new capabilities to existing bioreactor platforms, and harmonize global bio-process information transfer. Our current product family provides comprehensive measurement and control solutions for upstream processes in the biotech and pharmaceutical industries. For more information, please visit us at www.finesse.com.

About Nova Biomedical
Nova Biomedical is committed to continue its technology leadership with advanced products that provide better, faster diagnostic information. We continue to innovate biotechnology instruments that allow faster, more economical development of drugs and other therapeutic products.

Media: Barbara Paldus, 408-327-6623